Skip to main content

Table 5 Distribution of Hepatitis B Quality of Life subscale scores by some socio-demographic and disease-related characteristics of patientsa

From: Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey

Variable Psychological Well-Being Anticipation anxiety Vitality Stigma Vulnerability Total score
Gender p :<0,001 p :<0,001 p :<0,001 p:0,921 p :0,003 p :0,001
 Male 87,5 (70;97,5) 76,7 (56,7;93,3) 80 (64;92) 90 (73,3;100) 80 (60;93,3) 82,8 (67,1;92,8)
 Female 85 (65;95) 73,3 (50;93,3) 76 (60;88) 90 (73,3; 100) 80 (60;93,3) 80 (63,6;91,4)
Marriage status p :0,001 p :<0,001 p:0,341 p :<0,001 p :<0,001 p :0,002
 Married 87,5 (70;95) 76,7 (56,7;93,3) 80 (64;88) 90 (73,3;100) 80 (60;93,3) 82,1 (67,1;92,8)
 Single 82,5 (65;95) 73,3 (50;90) 76 (60;92) 86,7 (66,7;100) 73,3 (53,3;93,3) 78,6 (62,8;90,7)
Education level p:0,441 p :0,121 p :<0,001 p:0,001 p:0,089 p:0,881
 Elementery school and under 87,5 (67,5;95) 76,7 (53,3;93,3) 76 (60;88) 93,3 (73,3;100) 80 (60;93,3) 81,4 (65,7;93,6)
 Middle school 82,5 (68;95) 73,3 (50;90) 76 (64;88) 86,7 (66,7;100) 80 (53,3;93,3) 80,7 (62,8;91,4)
 High school 87,5 (70;95) 76,7 (54,2;90) 80 (64;92) 90 (73,3;100) 80 (60;93,3) 82,1 (67,8;92,8)
 University 85 (70;97,5) 76,7 (56,6;90) 80 (68;92) 90 (73,3;100) 80 (60;93,3) 82,1 (67,1;91,4)
Regular income p :0,005 p :<0,001 p :<0,001 p :<0,001 p :<0,001 p:0,077
 Yes 90 (72,5;97,5) 80 (60;93,3) 80 (64;92) 93,3 (76,7;100) 80 (60;93,3) 84,3 (70;93,6)
 No 80 (62,5;95) 70 (46,7;86,7) 72 (56; 88) 86,7 (66,7;100) 73,3 (53,3;93,3) 77,1 (60,7;89,3)
Family members with hepatitis B p:0,328 p :0,015 p :<0,001 p:0,082 p :0,002 p:0,097
 Present 85 (67,5;95) 73,3 (53,3;90) 76 (60;88) 90 (73,3;100) 80 (60;93,3) 80,7 (65;91,4)
 Not 87,5 (67,5;97,5) 76,7 (54,2;93,3) 80 (64;92) 90 (73,3;100) 80 (60;93,3) 82,9 (67,1;92,8)
Received treatment for hepatitis B p :0,001 p:0,070 p:0,179 p:0,066 p:0,917 p :0,011
 Yes 85 (70;95) 76,7 (53,3;90) 76 (64;88) 90 (73,3;100) 80 (60;93,3) 80,7 (66,4;91,4)
 No 87,5 (67,5;95) 76,7 (53,3;93,3) 80 (64;88) 90 (73,3;100) 80 (60; 93,3) 82,1 (65;92,8)
Other chronic disease p :0,003 p:0,385 p :<0,001 p:0,988 p :0,010 p :<0,001
 Present 85 (65;95) 76,7 (53,3;93,3) 72 (56;88) 90 (73,3;100) 80 (53,3;93,3) 79,3 (63,6;91,4)
 Not 87,5 (70;95) 76,7 (53,3;93,3) 80 (64;92) 90 (73,3;100) 80 (60;93,3) 82 (66,4;92,1)
Hospital type p :<0,001 p :<0,001 p :<0,001 p :<0,001 p :<0,001 p :<0,001
 Training hospital 90 (72,5;95) 80 (60;93,3) 84 (68;88) 93,3 (76,7;100) 80 (66,7;93,3) 85,7 (70,7;93,6)
 University hospital 85 (65;97,5) 73,3 (50;86,7) 76 (60;88) 90 (70;100) 73,3 (53,3;93,3) 80 (63,6;90)
 Other 80 (62,5;95) 70 (46,7;86,7) 72 (56;88) 86,7 (63,3;100) 73,3 (53,3;86,7) 76,4 (59,3;88,6)
HBeAg status p :<0,001 p:0,098 p :0,015 p :0,022 p :<0,001 p :<0,001
 Positive 82,5 (65;95) 73,3 (50;90) 76 (60;88) 86,7 (66,7;100) 73,3 (53,3;93,3) 79,3 (62,9;91,4)
 Negative 87,5 (67,5;95) 76,7 (53,3;93,3) 80 (64;88) 90 (73,3;100) 80 (60;93,3) 82,1 (66,4;92,1)
  1. aValues were not normally distributed; thus; median (% 25; % 75) scores are presented in cells, bold data reflected a statistical significance